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Introduction: Clerodendrum capitatum (Willd) Schumach. & Thonn (Lamiaceae) is used in African traditional medicine for the treatment of 
malaria, hypertension, obesity, jaundice and diabetes however there is lack of experimental data on its possible toxicity. This study investigated 
the acute and 28 days sub-chronic toxicity of C. capitatum in Wistar rats. Methods: In acute toxicity tests, a single administration of the 
hydroethanolic C. capitatum leaf extract (5 g/kg) was given orally to 5 female rats. The general behavior, adverse effects and mortality were 
recorded for up to 14 days post treatment. On the 15th day, the rats were weighed and euthanized for necropsy. In sub-chronic toxicity tests, the 
extract (4, 8 and 16 g/kg/day) was given orally to both male and female rats for 28 days. The animal body weight was recorded throughout the 
experiment, while hematological and biochemical parameters of blood and relative organs weights were evaluated on the 29th day. 
Results: Clerodendrum Capitatum did not cause any death or any hazardous symptoms of acute toxicity, showing an LD50 higher than 5 g/kg. 
Sub-chronic administration of C. capitatum resulted in no noticeable changes in weight gain and water or food consumption. White blood cells and 
hemoglobin increased while urea concentration, liver enzymes, total cholesterol and glucose concentrations significantly decreased in treated 
animals. No changes in macroscopical aspect of organs were observed in the animals. Conclusion: These results showed that acute or sub-
chronic oral administration of the hydroethanolic leaf extract of Clerodendrum capitatum may be considered as relatively free of toxicity. 
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Introduction 
 
The use of medicinal plants to treat various ailments is as old as the 
world. It is well known throughout history and has always been part 
of human culture. The World Health Organization (WHO) estimates 
that up to 80% of the world’s population relies on traditional 
medicinal system for some aspects of primary health care [1]. In 
African ethnomedicines, it is well known that traditional healers 
make use of a large variety of herbs in the treatment of parasitic 
diseases including malaria and a wide proportion of herbal remedies 
dispensed by traditional healers are widely believed by their clients 
to be effective [2,3]. Such plants can play an important role in drug 
discovery and their studies are logical research strategies in the 
search for new drugs [4]. In some countries, government 
encourages the use of indigenous forms of medicine rather than 
expensive imported drugs. In the USA, nearly one in three people 
uses some kind of alternative medical treatment [5]. Previous 
studies have reported the effectiveness of medicinal plants in 
treating of various disease conditions such as liver problems [6], 
circulatory and respiratory problems [7], febrile illnesses [8] and 
diarrhea [9]. However, despite the profound therapeutic advantages 
possessed by some of the plants, some constituents of medicinal 
plants have been shown to be potentially toxic, carcinogenic and 
teratogenic [10,11]. Moreover, it is known that the consumption of 
medicinal plants without evaluating their efficacy and safety can 
result in unexpected or toxic effects that may affect the physiology 
of different organs in the human body. Liver and kidney are the first 
targets in toxicological evaluation because they are involved in the 
metabolism and excretion of chemical compounds. Renal damage 
has also been associated with the use of medicinal plants in the 
treatment of various diseases [12]. 
  
Clerodendrum capitatum (Willd) Schumach. & Thonn (Lamiaceae) is 
an indigenous tropical Africa perennial undershrub, fast growing, 
erect, well branched, and grows up to 0.5-2 m high [13]. In Togo 
the leaves of the plant are traditionally used in the treatment of 
malaria [14]. Based on ethno botanical report in the maritime region 
of Togo, C. capitatum is frequently used to treat high blood 
pressure related to hypertension and also to alleviate obesity, 
jaundice and constipation. In Nigeria, the plant is used to treat 
diabetes mellitus, obesity and high blood pressure [15]. 
Pharmacological studies of the Clerodendrum genus demonstrated 
biological activities such as antitumorgenic [16,17], hypoglycemic, 
and hypolipidemic [18]. Despite the widespread use of C. capitatum, 
there is lack of experimental data on its possible toxicity. Thus, the 
present investigation was undertaken to provide data on the safety 
of C. capitatum by focusing on the acute toxicity and 28 days sub-
chronic toxicity of the hydroethanolic leaf extract of C. 





Plant material and extraction 
  
Fresh leaves of C. capitatum were collected in August 2013 from 
Adidigomé, a locality at North West of Lomé (Togo). Botanical 
authentication was confirmed at the Department of Botany, 
University of Lomé, where a voucher specimen of C. capitatum was 
deposited at the herbarium (N° TG12806). The leaves were washed, 
air-dried under air conditioner for three days and were coarsely 
powdered. The powder (300 g) was macerated at room temperature 
with 3 L of ethanol-water (8:2, v/v) for 72 h. The solvent was 
removed using a rotary vacuum evaporator (Buchi, Japan) at 40°C 
and the crude extract, representing a yield of approximately 12.7% 
(w/w), was stored at -4°C until administrated doses preparation, 
when it was dissolved in sterilized distilled water. 
  
Animals and treatment 
  
Wistar rats of either sex weighting 145-150 g (males) and 120-125 
g (females) used in the present study were provided by animals 
facilities of the Laboratory of Physiology, Pharmacology and 
toxicology of the Faculty of Sciences, University of Lomé. Animals 
were housed divided by sex in cages (Five rats per cage) at ambient 
temperature and humidity with a 12 hours day-light cycle, with free 
access to food and water ad libitum. Experimental protocols were 
based on World Health Organization Guidelines for care and use of 
laboratory animals, and the use of the animals was approved by the 
Ethics Committee of the University of Lomé, a branch of the 
National Ethics Committee for control and supervision of 




Healthy female Wistar rats were used in this study according to the 
Organization for Economic Cooperation and Development (OECD) 
revised up-and-down procedure for acute oral toxicity testing [19]. 
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Female rats were selected for the test because they are frequently 
more sensitive to the toxicity of test compounds than males. The 
extract was dissolved in sterilized distilled water in a volume of 10 
mL/kg body weight of experimental animal by oral administration. 
All the animals were fasted overnight, but with free access to water 
and they were weighed before the extract administration. Animals 
were randomly divided in two groups (n = 5 per group). The first 
group (control group) received distilled water orally. The second 
group (acute toxicity group) was treated as followed: a dose limit of 
5 g/kg was given to the first animal which was observed for 
mortality, signs of acute toxicity and behavioral changes (unusual 
aggressiveness, unusual vocalization, restlessness, sedation and 
somnolence, twitch, tremor, ataxia, catatonia, paralysis, convulsion, 
fasciculation, prostration and unusual locomotion and asphyxia) for 
the first thirty minutes and the first hour, then hourly for 5 h and, 
finally periodically until 48 h. If this first animal survived, then four 
additional animals were to be given the same 5 g/kg dose 
sequentially at 48 h intervals. All the experimental animals were 
individually observed daily for general behavioral and body weight 
changes, hazardous symptoms and mortality for a period of 14 days 
post treatment. The LD50 was predicted to be above 5 g/kg if three 
or more rats survived. At the end of the experimental period, all 
animals were weighed and sacrificed by cervical dislocation, and the 






The administered doses in this study were chosen based on the 
pharmacologically effective doses of the hydroethanolic extract from 
earlier hepatoprotective effects studies carried out in our laboratory 
in males Wistar rats. A total of 40 rats of either sex were used in 
this study. Rats were divided into 4 groups of 10 each (n = 10; 5 
males and 5 females per group) and their weights were recorded. 
Before treatment, rats were individually handled and carefully 
examined for abnormal behavior and appearance. The extract of C. 
capitatum, dissolved in sterilized distilled water, was administered 
orally once a day for 28 consecutive days in single doses of 0.4 g/kg 
(group I), 0.8 g/kg (group II) or 1.6 g/kg (group III), while the 
control rats (group IV) received sterilized distilled water. Animals 
were observed daily during the experimental period for mortality or 
morbidity, changes in posture, changes in skin fur, eyes, mucous 
membranes and behaviors. At the end of each week, the body 
weights of all the rats were recorded and doses of the extract were 
adjusted accordingly. At the end of the 28 days of administration, 
animals were fasted overnight, but allowed free access to water. On 
the 29th day they were anesthetized with ether and blood samples 
were collected via retro-orbital puncture using capillary tubes for 
hematological and biochemical studies respectively [20]. Blood 
samples for hematological analysis were collected in tubes 
containing Ethylene Diamine Tetra Acetic acid (EDTA) as 
anticoagulant whereas samples for biochemical analysis were 
collected into tubes without anticoagulant and centrifuged within 
one hour. After blood collection, the rats were sacrificed by clavicle 
dislocation. Organs such as liver, kidneys, sex organs (testes, 
seminal vesicles and epididymis for male rats; ovaries and uterus for 
female rats), brain, spleen, lungs, and heart were excised, washed 
immediately in NaCl (0.9%), weighed individually and examined 
macroscopically. 
  
Relative organ weights ratio 
  
The excised organs were weighed and the weight of each organ 
was multiplied by 100 and divided by the weight of the animal 
before sacrifice to obtain the relative organs weight (%) [21,22]. 
  
Hematological and biochemical analysis 
  
Blood samples collected in EDTA tubes were used for hematological 
analysis. Parameters included: red blood cell count, white blood cell 
count, hemoglobin, hematocrit, mean corpuscular volume, mean 
corpuscular hemoglobin, mean corpuscular hemoglobin 
concentration, platelets count and mean platelet volume were 
performed using an automatic hematological analyzer (ABX Pentra 
XL 80, France). The differential leukocyte count was performed with 
an optical microscopy (Optika, Italy) after hematological staining 
(fixation with May Grunwald and staining with Giemsa stain (Atom 
Scientific, UK)). In each case, 100 cells were counted. Blood 
samples collected in tubes without anticoagulant were used for 
biochemical analysis. They were allowed to clot and centrifuged at 
3000 rpm corresponding to 1107g force for 15 min using electric 
centrifuge (Shimadzu Scientific Corporation Tokyo, Japan) within 1 h 
after collection. The sera were separated, stored at -20°C and used 
for evaluation of biochemical parameters which include aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), alkaline 
phosphatase (ALP), creatinine, glucose, serum urea nitrogen, uric 
acid, total cholesterol, triglycerides, total protein, total bilirubin and 
direct bilirubin, a-amylases, chloride, potassium, sodium and 
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inorganic phosphorus using commercial kits purchased from Human 




The results are expressed as mean ± standard error of the mean 
(SEM). Statistical analysis was performed by one-way analysis of 
variance (ANOVA) followed by Tukey’s multiple comparison test to 
evaluate significant differences between groups. Results were 
considered to be significant at p < 0.05. All statistical analyses were 





In acute toxicity study, oral administration of hydroethanolic leaf 
extract of C. capitatum at the dose of 5 g/kg did not cause mortality 
or any clinical signs of acute toxicity in rats observed for a short 
period of 48 h and a long period of 14 days. All five female rats 
survived until the end of the observation period. No abnormality 




In sub-chronic toxicity study, daily oral administration of the 
hydroethanolic leaf extract of C. capitatum at the doses of 0.4 g/kg, 
0.8 g/kg and 1.6 g/kg for 28 consecutive days resulted in no 
noticeable changes in the general behavior of treated rats compared 
to controls. No lethality was recorded in either sex in control and 
treated groups at any of the doses administered during the 28 days 
of extract administration. No differences in food and water 
consumption were observed between the groups of rats. Likewise, 
no significant differences in body weight gain (Figure 1 and Figure 
2) or relative organ weights (Table 1, Table 2) were observed 
between control and treated groups. Macroscopic observations of 
organs of treated animals did not show any significant change in 
color and texture between control and treated groups. Both the 
control and treated rats appeared uniformly healthy at the end of 
and throughout the 28-day treatment period. Similarly, sub-chronic 
oral administration of the extract did not cause any significant 
change in hematological profile of male and female rats (Table 
3, Table 4). However, white blood cells and hemoglobin rate 
increased in treated animals. The extract did not cause any 
significant change in serum creatinine, total and conjugated 
bilirubins, total proteins, triglycerides, phosphorus, potassium, 
chlorine, sodium and uric acid in both male and female rats (Table 
5, Table 6). However, at 1.6 g/kg the extract decreased significantly 
(p<0.05) blood concentration of urea in both male and female rats 
as compared to control. In the same way, total cholesterol and 
glucose concentrations decreased significantly in both male and 
female rats. Liver enzymes (AST, ALT and ALP) also decreased in 





Medicinal plants are an important source of bioactive compounds 
and are used worldwide in traditional medicine for the treatment of 
various ailments. Although medicinal plants may have biological 
activities that are beneficial to humans, the potential toxicity of 
these bioactive substances has not been well established [22]. 
Moreover, despite the widespread use, few scientific studies have 
been undertaken to ascertain the safety and efficacy of traditional 
remedies [23]. Thus, the safety of these plants must be studied 
thoroughly to avoid their potential toxicity in human. To achieve this 
objective, the present investigation was performed to evaluate the 
possible acute toxicity and 28 days sub-chronic toxicity effects of 
hydroethanolic leaf extract of C. capitatum, used as a natural 
medicine in many African countries to alleviate many pathological 
conditions alone or in combination with many others medicinal 
plants organs by traditional healers in their receipt formulation. Data 
obtained from this study showed that C. capitatum in acute dose of 
5 g/kg, by oral route, did not produce any sign of toxicity in general 
behavior or death. All animals treated with the extract survived until 
the end of the 14 days observation period. No abnormality was 
found in organs at necropsy at the end of the experimental period. 
This suggests that the median acute toxicity value (LD50) of the 
extract is above 5 g/kg body weight. According to Kennedy et al. 
[24], substances that present LD50 higher than 5 g/kg by oral route 
may be considered practically non-toxic. Therefore, it can be 
suggest that acute toxicity of the hydroethanolic leaf extract of C. 
capitatum is devoid of acute oral toxicity. Similar results were 
observed by Mirtes et al. [25] and Caroline et al. [26] with other 
plants using the same toxicological method. 
  
A good extrapolation has been reported between toxicological 
insults in rats and humans; this is in contrast weaker when 
comparing humans and mice [27]. Therefore, oral intake of the leaf 
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of C. capitatum may be considered as safe. However, in an acute 
oral toxicity study by Adeneye et al. [15], C. capitatum aqueous 
fresh leaves extract was documented to be non-lethal in rats at 5 
g/kg but caused rapid-onset increased somatomotor activity, 
tachypnea, bilateral narrowing of the eyelids, tremor, piloerection, 
and increased feeding pattern in rats. Sub-chronic treatment did not 
produce any death or clinical signs of toxicity. There were no 
statistically significant differences (p > 0.05) in the body weight 
gain by the animals throughout the course of extract administration 
in all the doses compared with the control animals. This observation 
may indicate that extract did not alter the metabolic processes of 
the treated animals which may subsequently affect the hormones 
and body weight [28]. An important index to diagnose whether an 
organ has been exposed to injury is to calculate the organ-to-body 
weight ratio [22]. Hence, if rats are exposed to toxic substances the 
weight of the damaged organ will either increase or decrease as will 
the organ-to-body weight ratio. In the present study there were no 
significant changes in the relative weights of organs between the 
control and treated rats. This suggests no glossy toxic effect from 
the extract. Analysis of blood parameters is relevant to risk 
evaluation as any changes in the hematological and biochemical 
systems have a higher predictive value for human toxicity, when 
data are translated from animal studies [27]. In this study, the 
hematological profile of treated rats showed no significant difference 
with control group, except white blood cells and hemoglobin which 
increased in the groups treated with the hydroethanolic leaf extract 
of C. capitatum. Increase in white blood cells directly indicates the 
strengthening of the organism defense [29,30]. This elevation in 
total leucocytes count suggests that the extract contains biologically 
active compounds that have the ability to boost the immune system 
through increasing the population of defensive white blood cells. 
 
However, a global increase was observed in red blood cell count, 
hematocrit and hemoglobin concentration, implying that there may 
be a possible increase in erythropoiesis. Kidney functions were 
evaluated by means of serum urea, creatinine, sodium, potassium, 
chloride, uric acid and inorganic phosphorus. Increase blood 
creatinine is a good indicator of negative impact in kidney functions 
[31,32]. Moreover, serum creatinine and urea concentrations are 
used for the assessment of renal sufficiency [33]. Thus, higher than 
normal levels of serum creatinine and urea are indications of 
deficiency in renal function. In the present study, there were no 
significant changes in blood creatinine, uric acid, sodium, potassium, 
chloride and inorganic phosphorus. These results suggest that the 
kidney functions are not altered in animals treated with the extract. 
However, serum urea decreased in rats treated at the dose of 1.6 
g/kg. The decrease in serum urea concentration in the treated rats 
confirms that functioning of the kidney is normal. The increase 
levels of AST and ALT in the blood are associated with damage of 
hepatic cells [34,35]. Emerson et al. [36] also have reported that 
enhancement in the level of serum proteins is an indication of tissue 
injury and reflection of hepatic toxicity. Significant changes in such 
classical enzymes as ALP, ALT and AST suggest liver impairment, 
since these are reliable indices of liver toxicity [37], or altered 
integrity of cellular membrane as well as cell lyses or death [38]. As 
one of the biochemical parameters analyzed, AST is normally found 
in the cytoplasm and mitochondria of many cells, primarily in cardiac 
muscle, liver and skeletal muscle. Its concentration is much lower, 
however, in the kidney, pancreas and erythrocytes. Therefore, an 
increase in the serum levels of ALT, AST, ALP or total bilirubin 
indicates hepatic toxicity [39]. These changes occur in the blood 
when the hepatic cellular permeability is changed or when necrosis 
and cellular injury occurs. In the present investigation, sub-chronic 
administration of the extract caused decrease in the levels ALT, AST 
and ALP. No significant difference in the levels of total proteins, 
total bilirubin and conjugated bilirubin was found. This suggests that 
the extract may not only be toxic to the liver but could have 
hepatoprotective effects. 
 
Moreover, sub-chronic administration of the extract caused 
significant decrease in the level of glucose and total cholesterol; 
while there was no significant change in the levels of triglyceride 
although it decreased, suggesting that C. capitatum has 
hypoglycemic and hypolipidemic effects. Our data concerning 
glucose and total cholesterol and triglycerides are in agreement with 
those found by Adeneye et al. [15] who demonstrated that the fresh 
aqueous leaf extract of C. capitatum possesses hypoglycemic and 
hypolipidemic effects. Moreover these results confirmed the 
traditional use of this plant in the treatment of diabetes and obesity. 
In the present investigation, there was no significant change in 
serum level of a-amylases. The a-amylases catalyze the hydrolytic 
degradation of polymeric carbohydrates such as amylose, 
amylopectin and glycogen by cleaving 1,4-a-glucosidic bounds. 
Because of the sparsity of specific clinical symptoms of pancreatic 
diseases, a-amylases determinations are of considerable importance 
in pancreatic diagnostics. They are mainly used in the diagnosis and 
monitoring of acute pancreatitis. Hyperamylasemia does not, 
however, only occur with acute or in the inflammatory phase of 
chronic pancreatitis, but also in renal failure (reduced glomerular 
filtration), tumors of the lungs or ovaries, pulmonary inflammation, 
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diseases of the salivary gland, diabetic ketoacidosis or cerebral 
trauma. The results of our work demonstrated that C. capitatum did 





In conclusion, we summarize that acute (5 g/kg) and sub-chronic 
(0.4, 0.8 and 1.6 g/kg) toxicological evaluation of the 
hydroethanolic leaf extract of Clerodendrum capitatum may be 
considered as relatively free of toxicity, when given orally, because 
it did not cause any death, lethality nor produced any remarkable 
hematological and biochemical adverse effects in both male and 
female Wistar rats. Further investigations in the areas of mutagenic, 
teratogenic and carcinogenic effects are however needed. 
 
What is known about this topic 
 Clerodendrum capitatum exerts hypoglycemic and 
hypolipidemic effects. 
 Some constituents of medicinal plants have been shown 
to be potentially toxic. 
 Consumption of medicinal plants without evaluating their 
safety can result in unexpected or toxic effects. 
 
What this study adds 
 Clerodendrum capitatum may be considered as relatively 
free of toxicity when administrated orally during 28 days. 
 Clerodendrum capitatum leaf extract may contain 
biologically active compounds that have the ability to 
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Extract doses (mg/kg/day) 
400 800 1600 
Liver 3.59 ± 0.28 3.35 ± 0.14 3.27 ± 0.17 3.29 ± 0.09 
Kidney (right) 0.45 ± 0.02 0.38 ± 0.03 0.39 ± 0.02 0.41 ± 0.03 
Kidney (left) 0.45 ± 0.01 0.39 ± 0.02 0.40 ± 0.02 0.41 ± 0.02 
lungs 0.65 ± 0.05 0.55 ± 0.04 0.54 ± 0.03 0.64 ± 0.03 
Spleen 0.29 ± 0.02 0.27 ± 0.02 0.22 ± 0.01 0.27 ±0 .01 
Heart 0.34 ± 0.02 0.33 ± 0.01 0.34 ± 0.01 0.34 ± 0.01 
Testis (right) 0.76 ± 0.03 0.69 ± 0.03 0.46 ± 0.13 0.73 ± 0.03 
Testis (left) 0.75 ± 0.04 0.68 ± 0.02 0.46 ± 0.12 0.74 ± 0.03 
Epididymis 0.40 ± 0.02 0.36 ± 0.04 0.29 ± 0.05 0.32 ± 0.04 
Brain 0.99 ± 0.07 0.84 ± 0.07 0.84 ± 0.05 0.99 ± 0.06 
Seminal vesicle 0.85 ± 0.02 0.65 ± 0.05 0.76 ± 0.05 0.89 ± 0.09 
Values are expressed as Mean ± SEM (n = 5) 
 
 





Extract doses (mg/kg/day) 
400 800 1600 
Liver 3.53 ± 0.18 3.20 ± 0.20 3.36 ± 0.12 3.90 ± 0.14 
Kidney (right) 0.47 ± 0.02 0.41 ± 0.01 0.43 ± 0.01 0.44 ± 0.01 
Kidney (left) 0.45 ± 0.02 0.41 ± 0.02 0.45 ± 0.01 0.45 ± 0.02 
lungs 0.79 ± 0.03 0.77 ± 0.07 0.69 ± 0.02 0.83 ± 0.04 
Spleen 0.34 ± 0.01 0.29 ± 0.02 0.30 ± 0.01 0.33 ± 0.01 
Heart 0.40 ± 0.01 0.40 ± 0.02 0.36 ± 0.01 0.36 ± 0.00 
Ovary 0.05 ± 0.01 0.05 ± 0.01 0.04 ± 0.01 0.04 ± 0.01 
Uterus 0.66 ± 0.01 0.57 ± 0.01 0.58 ± 0.01 0.63 ± 0.01 
Brain 1.04 ± 0.07 0.92 ± 0.11 1.00 ± 0.07 1.13 ± 0.02 
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Extract doses (mg/kg/day) 
400 800 1600 
White blood cells (109/l) 7.82 ± 1.03 9.96 ± 0.76 9.48 ± 0.57 9.74 ± 1.23 
Red blood cells (1012/l) 8.09 ± 0.20 8.31 ± 0.11 8.36 ± 0.09 8.13 ± 0.08 
Hemoglobin (g/dl) 15.88 ± 0.21 16.42 ± 0.16 15.90 ± 0.18 16.06 ± 0.14 
Hematocrit (%) 44.88 ± 0.68 46.28 ± 0.59 44.46 ± 0.62 51.46 ± 5.68 
MCV (fl) 55.62 ± 1.20 55.76 ± 1.09 53.22 ± 0.75 56.70 ± 0.47 
MCH (pg) 19.60 ± 0.32 19.68 ± 0.23 18.96 ± 0.19 19.68 ± 0.14 
MCHC (%) 35.36 ± 0.29 35.42 ± 0.32 35.72 ± 0.25 34.82 ± 0.13 
Platelets (109/l) 654.00 ± 31.33 672.40 ± 21.44 698.00 ± 41.06 686.8 ± 24.14 
MPV (fl) 8.180 ± 0.11 8.16 ± 0.12 8.36 ± 0.040 8.00 ± 0.07 
Neutrophils (%) 20.60 ± 0.60 19.40 ± 0.40 20.00 ± 0.7 21.00 ± 1.81 
Eosinophils (%) 2.80 ± 0.86 1.80 ± 0.73 1.80 ± 0.91 1.80 ± 0.80 
Basophils (%) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Lymphocytes (%) 74.60 ± 1.60 77.20 ± 0.66 76.80 ± 1.02 75.80 ± 1.46 
Monocytes (%) 1.60 ± 0.67 1.60 ± 0.50 1.40 ± 0.74 1.80 ± 0.80 
Values are expressed as Mean ± SEM (n = 5). MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean 
corpuscular hemoglobin concentration; MPV: mean platelet volume 
 
 





Extract doses (mg/kg/day) 
400 800 1600 
White blood cells (109/l) 7.76 ± 0.66 8.82 ± 1.24 8.80 ± 0.68 8.96 ± 0.72 
Red blood cells (1012/l) 7.36 ± 0.16 7.48 ± 0.08 7.50 ± 0.09 7.46 ± 0.14 
Hemoglobin (g/dl) 14.82 ± 0.18 15.30 ± 0.23 15.14 ± 0.28 15.12 ± 0.182 
Hematocrit (%) 42.94 ± 0.58 43.56 ± 0.64 44.32 ± 0.80 43.74 ± 0.52 
MCV (fl) 58.38 ± 0.80 58.30 ± 0.64 59.12 ± 0.72 58.78 ± 1.03 
MCH (pg) 20.08 ± 0.26 20.40 ± 0.28 20.10 ± 0.23 20.22 ± 0.33 
MCHC (%) 34.46 ± 0.08 35.08 ± 0.30 34.10 ± 0.13 34.50 ± 0.08 
Platelets (109/l) 747.00 ± 16.74 699.60 ± 23.80 694.80 ± 28.48 797.60 ± 19.83 
MPV (fl) 8.06 ± 0.13 8.18 ± 0.17 8.26 ± 0.04 8.02 ± 0.07 
Neutrophils (%) 19.40 ± 0.67 19.40 ± 0.67 19.80 ± 0.96 20.00 ± 0.83 
Eosinophils (%) 1.80 ± 0.73 1.80 ± 0.58 1.20 ± 0.58 1.40 ± 0.40 
Basophils (%) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Lymphocytes (%) 76.80 ± 1.31 77.60 ± 0.8 78.00 ± 1.18 77.00 ± 1.04 
Monocytes (%) 2.00 ± 0.70 1.20 ± 0.48 1.00 ± 0.44 1.60 ± 0.50 
Values are expressed as Mean ± SEM (n = 5). MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean 
corpuscular hemoglobin concentration; MPV, mean platelet volume 
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Table 5: Effect of CECC on serum biochemical parameters in male rats 
Biochemical parameters Control 
Extract doses (mg/kg/day) 
400 800 1600 
Urea (g/l) 0.31 ± 0.01 0.27 ± 0.00 0.27 ± 0.01 0.25 ± 0.01a 
Glucose (g/dl) 0.86 ± 0.08 0.60 ± 0.04a 0.54 ± 0 .04a 0.60 ± 0.06a 
Creatinine (mg/l) 5.20 ± 0.20 5.40 ± 0.50 4.80 ± 0.20 4.80 ± 0.20 
ALT (U/l) 158.40 ± 8.18 156.00 ± 9.09 178.80 ± 9.50 151.20 ± 8.70 
ALT (U/l) 61.20 ± 5.16 55.20 ± 5.16 43.20 ± 3.49 58.80 ± 7.20 
Alkaline phsophatase (U/l) 300.00 ± 18.69 230.40 ± 26.06 190.80 ± 12.92b 253.20 ± 21.33 
Total bilirubin (mg/dl) 1.14 ± 0.13 1.19 ± 0.23 1.04 ± 0.04 0.84 ± 0.22 
Direct bilirubin (mg/dl) 0.21 ± 0.03 0.19 ± 0.02 0.15 ± 0.01 0.23 ± 0.02 
Total proteins (g/l) 53.84 ± 1.48 50.46 ± 2.29 53.45 ± 1.44 50.43 ± 2.92 
Total cholesterol (g/l) 0.72 ± 0.04 0.60 ± 0.01 0.58 ± 0.02a 0.57 ± 0.02a 
Triglycerides (g/l) 0.60 ± 0.09 0.64 ± 0.03 0.6 3± 0.06 0.53 ± 0.02 
amylases (U/l) 254.80 ± 8.14 265.60 ± 9.50 243.40 ± 2.06 255.20 ± 4.64 
Sodium (mmol/l) 140.40 ± 1.63 143.04 ± 1.20 143.60 ± 1.93 139.80 ± 2.53 
Potassium (mmol/l) 4.50 ± 0.21 4.44 ± 0.06 4.18 ± 0.29 4.74 ± 0.27 
Chlorine (mmol/l) 104.40 ± 7.71 104.00 ± 0.63 103.40 ± 1.40 103.00 ± 0.70 
Phosphorus (mg/l) 42.40 ± 3.44 40.60 ± 5.52 42.40 ± 5.69 34.60 ± 2.40 
Uric acid (mg/l) 17.44 ± 2.90 13.68 ± 0.72 14.71 ± 3.34 26.55 ± 3.96 
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Extract doses (mg/kg/day) 
400 800 1600 
Urea (g/l) 0.32 ± 0.01 0.30 ± 0.01 0.29 ± 0.01 0.23 ± 0.01a 
Glucose (g/dl) 0.85 ± 0.01 0.61 ± 0.03b 0.59 ± 0.03b 0.60 ± 0.06b 
Creatinine (mg/l) 5.40 ± 0.24 6.20 ± 0.20 5.10 ± 0.20 5.40 ± 0.24 
ALT (U/l) 159.60 ± 7.25 147.60 ± 6.99 165.60 ± 7.96 168.00 ± 3.79 
ALT (U/l) 69.60 ± 8.81 55.20 ± 2.24 42.00 ± 2.68b 45.60 ± 3.05a 
Alkaline phsophatase (U/l) 196.8 ± 7.91 189.6 ± 8.81 163.2 ± 6.94a 168.0 ± 6.84 
Total bilirubin (mg/dl) 1.06 ± 0.11 1.11 ± 0.08 0.80 ± 0.09 0.88 ± 0.21 
Direct bilirubin (mg/dl) 0.25 ± 0.06 0.15 ± 0.02 0.26 ± 0.05 0.23 ± 0.05 
Total proteins (g/l) 66.19 ± 3.59 57.38 ± 1.80 58.71 ± 3.03 59.30 ± 2.62 
Total cholesterol (g/l) 0.79 ± 0.08 0.59 ± 0.01a 0.57 ± 0.02a 0.56 ± 0.02a 
Triglycerides (g/l) 0.62 ± 0.04 0.73 ± 0.04 0.68 ± 0.05 0.60 ± 0.04 
amylases (U/l) 187.20 ± 8.97 223.60 ± 6.56 209.00 ± 6.80 230.20 ± 8.93 
Sodium (mmol/l) 142.2 ± 1.24 142.60 ± 2.04 142.00 ± 1.92 141.60 ± 1.36 
Potassium (mmol/l) 5.00 ± 0.58 4.12 ± 0.25 4.68 ± 0.16 4.54 ± 0.42 
Chlorine (mmol/l) 101.20 ± 1.93 102.00 ±1 .51 101.20 ± 0.73 100.80 ± 1.28 
Phosphorus (mg/l) 36.40 ± 4.50 29.60 ± 2.15 38.20 ± 3.77 38.00 ± 5.71 
Uric acid (mg/l) 20.00 ± 3.11 15.58 ± 1.64 23.64 ± 3.11 22.70 ± 1.44 
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Figure 1: Mean body weight gain in sub-chronic toxicity of the hydroethanolic leaf extract 





Figure 2: Mean body weight gain in sub-chronic toxicity of the hydroethanolic leaf extract 
of Clerodendrum capitatum in female rats 
 
